Treatment Group
Treatment Group
Mean difference
App-based Care-as-usual
N = 87 N = 82 ICER (95% CI)
IIALYs gained 0.71 ± 0.215 0.66 ± 0.250 0.043 \euro-3,696 (CI -6,716 to 12,712)
Costs 1,520 ± 3,425 1,680 ± 3,357 -161
ICUR (95% CI)
QALYs gained 0.89 ± 0.165 0.91 ± 0.145 -0.025 \euro6,379 (CI -4,128 to 12,769)
Costs 1,520 ± 3,425 1,680 ± 3,357 -161
IIALYs, Incontinence Impact Adjusted Life Years; ICER, Incremental Cost Effectiveness Ratio; QALYs, Quality Adjusted Life Years; ICUR, Incremental Cost Utility Ratio. * Three cases were excluded from the analyses because a large influence on the data due to outliers in costs. IIALYs, Incontinence Impact Adjusted Life Years; ICER, Incremental Cost Effectiveness Ratio; QALYs, Quality Adjusted Life Years; ICUR, Incremental Cost Utility Ratio. * Three cases were excluded from the analyses because a large influence on the data due to outliers in costs. IIALYs, Incontinence Impact Adjusted Life Years; ICER, Incremental Cost Effectiveness Ratio; QALYs, Quality Adjusted Life Years; ICUR, Incremental Cost Utility Ratio. * Three cases were excluded from the analyses because a large influence on the data due to outliers in costs. IIALYs, Incontinence Impact Adjusted Life Years; ICER, Incremental Cost Effectiveness Ratio; QALYs, Quality Adjusted Life Years; ICUR, Incremental Cost Utility Ratio. * Three cases were excluded from the analyses because a large influence on the data due to outliers in costs. IIALYs, Incontinence Impact Adjusted Life Years; ICER, Incremental Cost Effectiveness Ratio; QALYs, Quality Adjusted Life Years; ICUR, Incremental Cost Utility Ratio. * Three cases were excluded from the analyses because a large influence on the data due to outliers in costs. IIALYs, Incontinence Impact Adjusted Life Years; ICER, Incremental Cost Effectiveness Ratio; QALYs, Quality Adjusted Life Years; ICUR, Incremental Cost Utility Ratio. * Three cases were excluded from the analyses because a large influence on the data due to outliers in costs. IIALYs, Incontinence Impact Adjusted Life Years; ICER, Incremental Cost Effectiveness Ratio; QALYs, Quality Adjusted Life Years; ICUR, Incremental Cost Utility Ratio. * Three cases were excluded from the analyses because a large influence on the data due to outliers in costs. IIALYs, Incontinence Impact Adjusted Life Years; ICER, Incremental Cost Effectiveness Ratio; QALYs, Quality Adjusted Life Years; ICUR, Incremental Cost Utility Ratio. * Three cases were excluded from the analyses because a large influence on the data due to outliers in costs.